Answer
Alectinib is licensed for ALK-positive non-small-cell lung cancer, so a validated test is required to confirm that treatment target.
Sources for this answer
- Alecensa 150 mg Hard Capsules — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.